(Q50580303)

15 March 2018

meta-analysis

0 references

title

Meta-analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4. (English)

1 reference

15 March 2018

0 references

1 reference

1 reference

1 reference

1 reference

Mohammad S Khuroo

1

1 reference

15 March 2018

Mehnaaz S Khuroo

series ordinal

2

1 reference

15 March 2018

Salim T Dahab

series ordinal

3

1 reference

15 March 2018

language of work or name

English

0 references

publication date

1 November 2004

1 reference

15 March 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

15 March 2018

volume

20

1 reference

15 March 2018

page(s)

931-938

1 reference

15 March 2018

issue

9

1 reference

15 March 2018

Hepatitis C virus infection

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Hepatitis C genotypes and subtypes in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

The hazards of scoring the quality of clinical trials for meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02208.X

10.1111/J.1365-2036.2004.02208.X

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

PubMed ID

15521839

1 reference

15 March 2018